NCT06566352 Different Methods to Minimize Blood Loss During Laparoscopic Myomectomy; A Randomized Controlled Clinical Trial
| NCT ID | NCT06566352 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zagazig University |
| Condition | Different Methods to Minimize Blood Loss During Laparoscopic Myomectomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2025-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-05-01 with a primary completion date of 2025-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Laparoscopic myomectomy with temporary bilateral uterine artery occlusion or intramyometrial injection of diluted epinephrine will be important to reduce intraoperative bleeding, time of operation and hospitalization period after laparoscopic myomectomy.
Eligibility Criteria
Inclusion Criteria: 1. Women aged from 18 to 39 years. 2. Symptomatizing Women (heavy menstrual bleeding or subfertility). 3. FIGO stage (3-7) by ultrasound. 4. Only uterine corpus fibroid. 5. Up to three fibroids by ultrasound. 6. No previous hormonal treatment. Exclusion Criteria: 1. Patients with bleeding tendency. 2. Patients who refuse to participate in the study or uncooperative patients. 3. Current pregnancy. 4. Any retroperitoneal surgery at pararectal space. 5. More than one cesarean delivery.
Frequently Asked Questions
Who can join the NCT06566352 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 39 Years, studying Different Methods to Minimize Blood Loss During Laparoscopic Myomectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06566352 currently recruiting?
Yes, NCT06566352 is actively recruiting participants. Visit ClinicalTrials.gov or contact Zagazig University to inquire about joining.
Where is the NCT06566352 trial being conducted?
This trial is being conducted at Zagazig, Egypt.
Who is sponsoring the NCT06566352 clinical trial?
NCT06566352 is sponsored by Zagazig University. The trial plans to enroll 60 participants.